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Abstract 
In this study, a new in vitro continuous colonic fermentation model of Salmonella infection 
with immobilized child fecal microbiota and Salmonella serovar Typhimurium was developed 30 
for the proximal colon. This model was then used to test the effects of two amoxicillin 
concentrations (90 and 180 mg day-1) on microbial composition and metabolism of the gut 
microbiota and on Salmonella serovar Typhimurium during a 43-day fermentation. Addition 
of gel beads (2%, v/v) colonized with Salmonella serovar Typhimurium in the reactor resulted 
in a high and stable Salmonella concentration (log 7.5 cell number mL-1) in effluent samples 35 
and a concomitant increase of Enterobacteriaeceae, Clostridium coccoides- Eubacterium 
rectale and Atopobium populations and a decrease of bifidobacteria. During amoxicillin 
treatments, Salmonella concentrations decreased while microbial balance and activity were 
modified in agreement with in vivo data with a marked decrease of Clostridium coccoides-
 Eubacterium rectale and an increase in Enterobacteriaceae. After interruption of antibiotic 40 
addition, Salmonella concentration increased again to reach values comparable to that 
measured before antibiotic treatments, showing that our model can be used to simulate 
Salmonella shedding in children as observed in vivo. This in vitro model could be a useful 
tool for developing and testing new antimicrobials against enteropathogens. 
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Introduction  45 
Salmonellosis is one of the most common and widely distributed foodborne diseases 
worldwide. It is associated with two types of symptoms, caused by different serovars of 
Salmonella enterica subsp. enterica: typhoid fever (mainly caused by serovar Typhi, 
Paratyphi and Sendai) which is more common in developing countries; and gastroenteritis 
(mainly caused by serovar Typhimurium and Enteritidis) also encountered in developed 50 
countries (Coburn et al., 2007). In Europe, 176,395 cases of salmonellosis infections (i.e. 38 
for 100 000 habitants) have been declared in 2005, with a major proportion (20%) of young 
children less than 5 years of age (The European Food Safety Authority & European Center for 
Disease Prevention and Control, 2006). In children, dehydration associated with diarrhea can 
become severe and life-threatening (Rosanova et al., 2002), therefore effective antimicrobials 55 
are essential drugs for treatment. Antimicrobials most widely regarded as optimal for treating 
diarrheal diseases caused by Salmonella serovar Typhimurium in children are third-generation 
cephalosporins, because quinolones and fluoroquinolones are generally not recommended due 
to their toxicity on immature cartilage and the possible emergence of resistant pathogens 
(Schaad, 2005). The earlier drugs, chloramphenicol, amipicillin, amoxicillin and 60 
trimethoprim-sulfamethaoxazole, are also used as alternatives (Frye & Fedorka-Cray, 2007; 
World Health Organization, 2008). However, the emergence of Salmonella isolates with 
multiple-drug resistance urges the need for alternatives to antibiotherapies (White et al., 2001; 
World Health Organization, 2008). Valuable models of Salmonella infection are therefore 
needed to develop and test new treatments, in particular for young human populations. 65 
To our knowledge, there is currently no suitable model to test the effects of new 
antimicrobials on both enteropathogens and intestinal bacteria. Animal models, such as 
bovine or streptomycin-pretreated mice models for Salmonella infection do not reproduce the 
human intestinal microbiota and are dedicated for studying host-pathogen interactions 
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(Hapfelmeier & Hardt, 2005). Moreover, in vivo studies are difficult to perform due to cost, 70 
ethical problems and high interindividual variations. By contrast, in vitro models are much 
less expensive, simpler to handle and could be a good alternative for testing new 
antimicrobial treatments in a first screening phase; but current models are not suitable for 
intestinal infections. The continuous culture models for human intestinal microbiota are 
mainly based on the original model of Macfarlane et al. (1998) and inoculated with diluted 75 
feces. These systems have several limitations due to the planktonic state of bacterial 
populations, leading to limited microbial stability and cell density compared to the colon; they 
are also not suited for long-term experiments with enteropathogens since exogenous bacteria 
are rapidly washed out of the system (Blake et al., 2003; Carman et al., 2004; Carman & 
Woodburn, 2001; Payne et al., 2003). Recently, we developed and validated a new model of 80 
infant and adult colonic fermentation with fecal microbiota immobilized in gel beads in 
anaerobic continuous-flow cultures (Cinquin et al., 2006a; Cinquin et al., 2006b; Cleusix et 
al., 2008; Macfarlane & Macfarlane, 2007). This new model has conditions that are more akin 
to that of the intestinal system and has the following characteristics: bacteria growing in 
biofilm structures; high cell density in gel beads and in reactor effluents (up to 1011 cells mL-1 85 
or g-1); high stability and reactivity to changing conditions of the intestinal fermentation; good 
protection of sensitive bacteria from shear and oxygen stresses; and prevention of washout 
and loss of less competitive bacteria.  
In this study we developed an in vitro model of intestinal fermentation with immobilized 
feces simulating intestinal Salmonella infections and long-term shedding in children. We 90 
hypothesized that addition of colonized beads with Salmonella serovar Typhimurium in the 
intestinal fermentation model containing an immobilized child microbiota would cause a 
stable infection of Salmonella in gel beads and in effluent samples. The effect of two 
antibiotic treatments on Salmonella serovar Typhimurium, as well as on the main bacterial 
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populations and metabolism of child’s microbiota were tested during the same continuous 95 
culture and compared with in vivo data to validate the model. 
Materials and methods 
Bacterial strain 
Salmonella enterica subsp. enterica serovar Typhimurium M557 (sseD::aphT ∆invG) 
(S. Typhimurium) was supplied by Prof. W. Hardt (Institute of Microbiology, ETH, Zurich, 100 
Switzerland). Sensitive to amoxicillin, this strain is a low virulent derivative of S. 
Typhimurium wild-type strain SL1344 lacking SPI-1 effector proteins (Hapfelmeier et al., 
2004). It was routinely cultivated in tryptone soya broth (TSB, Oxoid, Basel, Switzerland) 
overnight at 37 °C in aerobiosis. 
Antibiotic  105 
In human practice, Clamoxyl®/-RC (GlaxoSmithKline) containing amoxicillin as active 
compound, is a moderate-spectrum β-lactam antibiotic that can be used to treat salmonellosis 
in children (25-75 mg kg-1 day-1) (Moulin et al., 2003; Fachinformation des Arzneimittel-
Kompendium der Schweiz®, 2007). It is bactericidal against a wide range of Gram-positive 
and Gram-negative bacteria, including sensitive Salmonella with minimum inhibitory 110 
concentrations (MIC) ranging from 1 to 5 µg mL-1 for 90% of tested strains (Fachinformation 
des Arzneimittel-Kompendium der Schweiz®, 2007). For the experiment, pure amoxicillin 
(Sigma-Aldrich, Buchs, Switzerland) was used. 
Feces collection and bacterial immobilization 
The fecal sample used for immobilization was collected from a healthy 2 year-old child, who 115 
had not received antibiotics at least 3 months before the experiment. The fecal sample was 
maintained in anaerobiosis and immobilized in 1-2 mm gel beads composed of gellan (2.5%, 
 - 6 - 
w/v) and xanthan (0.25%, w/v) gums and sodium citrate (0.2%, w/v), as already described 
(Cleusix et al., 2008). Gel beads (60 mL) were then transferred into a stirred glass reactor 
(Sixfors, Infors, Bottmingen, Switzerland) with 140 mL of fresh nutritive medium simulating 120 
a child chyme (presented below). The entire process was completed under anaerobic 
conditions within 3 h after defecation. 
S. Typhimurium immobilization was done one day before reactor inoculation using the same 
procedure as for fecal samples, but in aerobiosis under a sterile bench. Salmonella beads 
(10 mL) were colonized overnight in 200 mL TSB at 37 °C in aerobiosis without pH-control. 125 
A fresh bead sample (0.5 g) was used to inoculate the reactor on day 11 and the rest was 
stored frozen (0.5 g aliquots) in 20% glycerol at -80 °C. 
Nutritive medium 
The nutritive medium used to feed the reactor was similar to that previously described by 
Macfarlane et al. (1998) for simulating an adult ileal chyme, with one modification; the bile 130 
salt concentration was reduced from 0.4 to 0.05 g L-1 to reproduce the ileal chyme of a young 
child. A solution of vitamins described by Michel et al. (1998) and sterilized by filtration 
(Minisart 0.2 µm, Sartorius, Göttingen, Germany) was added (0.5 mL l-1) separately to the 
autoclaved (15 min, 121 °C) medium.  
Experimental setup and sampling 135 
A single-stage reactor based on the model described by Cinquin et al. (2004) was used to 
mimic the microbial ecosystem of a child’s proximal colon. Batch fermentations were first 
carried out to colonize the fecal beads for 2 days. During colonization, the nutritive medium 
was aseptically replaced by fresh nutritive medium every 12 h. Temperature (37 °C) was 
automatically controlled and pH was maintained at 5.7 by adding NaOH (5N). Anaerobic 140 
conditions were maintained during the whole fermentation by a continuous flow of pure CO2 
in the headspace. The continuous fermentation was carried out in the same reactor connected 
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to a stirred feedstock vessel containing sterile nutritive medium continuously flushed with 
CO2 and maintained at 4 °C and to an effluent receiving vessel. Continuous medium feeding 
was carried out using peristaltic pumps (Reglo analog, Ismatec, Glattbrugg, Switzerland) 145 
delivering a feed flow rate of 40 mL h-1 for a mean retention time of 5 h. This time was used 
to simulate the residence time in a child proximal colon, with a pH of 5.7 (Fallingborg et al, 
1990). 
The 43-day continuous fermentation was divided into 6 periods of 5 to 9 days (Figure 1). First 
the system was stabilized (STyphi 0; days 3-10), then 0.5 g of beads colonized with 150 
S. Typhimurium (days 11 and 13) were added to the system followed by a second stabilization 
period (STyphi I; days 14-20) and two antibiotic treatments (ATB I [214 µg mL-1 thrice a 
day]; days 21-25 and ATB II [428 µg mL-1 thrice a day]; days 35-39) intercalated with a third 
stabilization period without antibiotic (STyphi II, day 26-34). Amoxicillin was added directly 
in the reactor three times per day (at 9 a.m., 2 p.m. and 6 p.m.) to reach total concentrations of 155 
90 mg day-1 (ATB I) and 180 mg day-1 (ATB II). According to the Fachinformation des 
Arzneimittel-Kompendium Schweiz®, the average oral dose (divided into three doses) of 
Clamoxyl®/- RC is 50 mg kg-1 day-1 for young children (2 to 12 year-old), with an absorption 
rate between 70 and 90% in the gastrointestinal tract. On the basis of two absorption rates of 
70 and 85% we calculated that 90 to 180 mg day-1 amoxicillin should reach the colon for a 160 
12 kg-child receiving 600 mg amoxicillin per day. On the last evening of ATB I (day 25) and 
II (day 39), the reactor was briefly stopped and the medium was entirely pumped out of the 
reactor after beads had settled. A new medium without antibiotic (Stab II and III) was 
immediately added. Effluent samples (10 mL) were collected daily for metabolites (short-
chain fatty acids [SCFA], and lactate) and fluorescent in situ hybridization (FISH) analyses. 165 
The pseudo-steady state for each period was reached when bacterial populations in the reactor 
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effluent did not change by more than 0.5 log units during 4 consecutive days (Cinquin et al., 
2006). 
During antibiotic treatments, effluent samples were collected before adding the first daily 
antibiotic dose. 170 
Bacterial enumeration with FISH and microscopy 
FISH analyses coupled with microscopy were performed for total bacteria and Salmonella 
enumeration as described by Cinquin et al. (2006a) on fermentation samples (1.5 mL) from 
the last 3 days of each pseudo-steady-state period. Total bacteria were stained with 4’, 6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich, Buchs, Switzerland) and S. Typhimurium 175 
was targeted with Sal 3, a Cy3-labelled oligonucleotide probe (Microsynth, Balgach, 
Switzerland) with hybridization conditions described by Nordentoft et al. (1997). 
Bacterial enumeration with FISH and flow cytometry 
FISH analyses coupled with flow cytometry were performed based on the method described 
by Zoetendal et al. (2002) with some modifications. Briefly, 100 µL of fixed fermentation 180 
samples (1.5 mL) and fixed feces (1.5 mL) were centrifuged (9000 g, 3 min) and the pellet 
was washed once in Tris-EDTA buffer (100 mM Tris/HCl, 500 mM EDTA, pH 8) before 
incubation for 10 min at room temperature in 100 µL of Tris-EDTA buffer supplemented with 
lysozyme (170’800 U mL-1) and proteinase K (6 µg mL-1) to destroy protein-clusters formed 
during both antibiotic treatment periods which interfered with flow cytometry detection. After 185 
removing the lysozyme solution by centrifugation (9000 g, 3 min) and washing the pellet 
once with 100 µL of fresh hybridization buffer (900 mM NaCl, 20 mM Tris/HCl, 0.1% SDS, 
30% formamide, pH 8), cells were resuspended in 300 µL of hybridization buffer, 
homogenized and divided into 10 aliquots of 25 µL. With exception of the negative control, 
aliquots were hybridized overnight at 35 °C with 50 ng µL-1 of Cy5-labeled probes (Table 1). 190 
Since hybridization conditions described for Sal 3 (Nordentoft et al., 1997) slightly differed 
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from conditions used in flow cytometry, the Sal 3 probe specificity was tested again with 
hybridization conditions used for flow cytometry (Table 1). 
After hybridization and to remove non-specific binding of probes, 900 µL of warm washing 
buffer (64 mM NaCl, 20 mM Tris/HCl, 5 mM EDTA, 0.1% SDS, pH 8) was added and 195 
samples were incubated at 37 °C for 20 min. A last centrifugation step was performed 
(9000 g, 3 min) before resuspending the pellet in 300 µL of cold potassium citrate buffer 
(10 mM Tris/HCl, 1 mM EDTA, 30 mM potassium citrate, pH 7.4). A 50 µL aliquote was 
diluted with 400 µL of potassium citrate buffer to obtain a final bacterial concentration of 
about 108 bacteria per mL. A volume of 0.5 µL of diluted (1/10’000) SYBR Green I 200 
(Invitrogen AG, Basel, CH) was added at least 15 min before each measurement in order to 
differentiate bacteria from non-bacterial material. To determine bacterial cell numbers, 50 µL 
of Flow-CountTM Fluorospheres (Beckman Coulter International SA, Nyon, CH) at known 
concentrations (1012 beads µL-1) were added just before data acquisition. Samples were 
passed through a Cytomics FC 500 (Beckman Coulter International SA, Nyon, Switzerland) 205 
equipped with an air-cooled argon ion laser emitting 20 mW at 488 nm and a Red Solid State 
Diode laser emitting 25 mW at 633 nm. The 633 nm laser was used to detect red fluorescence 
of bacteria hybridized with Cy5-labeled probes (PMT4 in a 655 nm long pass filter) and the 
488 nm laser was used to measure the forward angle light scatter (FSC), the side angle light 
scatter and the green fluorescence conferred by SYBR Green I (PMT1 in a 525 nm band pass 210 
filter). The acquisition threshold was set in the forward scatter channel to the minimum. The 
flow rate was set at 1,000-3,000 events s-1 and 100,000 events were stored in list mode files. 
Data were analyzed using the CXP software (Beckman Coulter International SA, Nyon, 
Switzerland). A PMT1 histogram (green fluorescence) was used to evaluate the total number 
of bacteria stained with SYBR Green I. In this histogram, a gate which included the total 215 
number of bacterial cells in the sample was designed and used to make a PMT4 histogram 
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(red fluorescence). This PMT4 histogram was then used to determine the bacterial groups 
marked with Cy5-labelled probes. To quantify bacterial groups and total cells, a correction 
was made to eliminate background fluorescence, measured using the negative control NON-
EUB338-Cy5 probe, as described by Rigottier-Gois et al. (2003). Analyses were done in 220 
duplicate. 
Metabolite analyses 
SCFA (acetate, propionate, butyrate and formate) and lactate concentrations were determined 
by HPLC as previously described (Cleusix et al., 2008). Each analysis was done in duplicate. 
Mean metabolite concentrations were expressed in mM. 225 
Statistical analyses 
A one-way ANOVA was performed using SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, 
USA) to test the effects of the different treatments on bacterial and metabolite concentrations 
measured during the pseudo-steady-state periods (mean of 3 successive days) in effluent 
samples. Treatment means were compared using the Tukey’s test with the probability level of 230 
P < 0.05. Data in the text are means ± SD. 
Results 
Microbial populations analyzed by FISH-flow cytometry 
The child fecal sample used for immobilization showed a total population of 10.2 ± 0.1 log10 
cells g-1, and was highly dominated by bifidobacteria (9.8 ± 0.1 log10 cells g-1). Mean 235 
concentrations of major bacterial populations measured in protease treated fermentation 
samples by FISH-Flow cytometry during the last three days of each experimental period are 
shown in Table 2. The predominant bacterial genus in the reactor effluents during the whole 
fermentation (except during STyphi I) was Bifidobacterium spp., initially followed by 
 - 11 - 
Clostridium coccoides-Eubacterium rectale and Bacteroides-Prevotella groups. No 240 
Salmonella or other Enterobacteriaceae were detected during STyphi 0. Following addition 
of S. Typhimurium-colonized beads (11.1 log10 cells (g bead)-1) to the reactor (days 11 and 
13; STyphi I), a high concentration of Salmonella (7.5 ± 0.1 log10 cells mL-1) was measured in 
effluent samples at the end of the first stabilization period (STyphi I, Table 2). Furthermore, 
the intestinal microbial balance largely changed compared with STyphi 0, with a significant 245 
decrease of bifidobacteria (minus 1.2 log10 unit) and a significant increase of 
Enterobacteriaceae, Atopobium spp. and the C. coccoides- E. rectale group. During this 
period (STyphi I), the C. coccoides- E. rectale group became the predominant bacterial group. 
Addition of amoxicillin (90 mg day-1, ATB I) induced a significant decrease in Salmonella 
concentration (more than 1.5 log10 units) compared with STyphi I (Table 2) and a shift in the 250 
different bacterial concentrations, which returned to values not significantly different from 
STyphi 0 (P > 0.05). The only exception was Enterobacteriaceae which in contrast to 
Salmonella, did not decrease during ATB I and remained significantly higher than during 
STyphi 0. During STyphi II with no antibiotic, most bacterial populations (including 
Salmonella) went back to values similar to STyphi I, except for Bifidobacterium spp. and C. 255 
coccoides- E. rectale concentrations which were significantly higher and lower, respectively. 
The second amoxicillin treatment (180 mg day-1, ATB II) induced similar changes as during 
ATB I, but the effects on bacterial populations measured during the last three days were 
significant only for Salmonella and the C. coccoides- E. rectale group. Finally, during the last 
stabilization period without antibiotic (STyphi III), bacterial populations went back to values 260 
similar to STyphi 0, except for Salmonella and total Enterobacteriaceae which remained 
significantly higher than for STyphi 0. No effect of treatments was observed on total bacteria 
or on Bacteroides concentrations during the whole fermentation. 
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Microbial populations analyzed by FISH-microscopy 
Bacterial analyses with FISH coupled to microscopic counts for total bacteria and 265 
S. Typhimurium used to monitor overtime the fermentation process corroborated data 
obtained with flow cytometry, with a significant decrease in Salmonella concentration during 
ATB I and II. No protease treatment was applied to these samples. However, a more 
pronounced inhibition of S. Typhimurium was measured with ATB I (minus 1.3 log10 units 
compared with STyphi I) compared with ATB II (minus 0.95 log10 units compared to 270 
STyphi II) (Figure 2). Furthermore cell aggregation was enhanced during antibiotic 
treatments. Total bacteria counts measured with FISH-microscopy were significantly lower 
(minus 1.2 log10 units) than by FISH-flow cytometry, decreased from STyphi 0 to STyphi I 
and remained stable during the subsequent treatments. 
Metabolites analyses 275 
The profiles of metabolite concentrations during the different fermentation periods are shown 
in Figure 3. Acetate was the main metabolite detected during STyphi 0 and throughout the 
fermentation (40-80 mM), whereas propionate and butyrate were present at low 
concentrations (≤ 20 mM). Lactate was also detected, although in variable concentrations (1-
20 mM), during the whole fermentation. Addition of S. Typhimurium induced a significant 280 
increase in butyrate (6.0 ± 0.1 and 13.5 ± 1.8 mM for STyphi 0 and STyphi I, respectively), 
whereas the other metabolites were not modified between the two periods (Table 3). ATB I 
dramatically decreased total metabolite concentration compared with STyphi I, especially due 
to a strong decrease in acetate, while formate and lactate increased. During STyphi II, 
metabolite concentrations went back to their previous levels of STyphi I, except for acetate 285 
and butyrate which remained significantly lower than during STyphi I. ATB II induced 
slightly different metabolite concentration changes compared with ATB I. A less pronounced 
decrease in acetate concentration was observed, whereas lactate and formate were 
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significantly more increased. During the last stabilization period (STyphi III) metabolite 
concentrations returned to their previous levels of STyphi II, except for propionate and 290 
formate (Table 3). 
Discussion  
Recently we successfully developed a new in vitro model of intestinal fermentation with 
immobilized fecal microbiota (Cinquin et al., 2004; Cinquin et al., 2006a; Cinquin et al., 
2006b; Cleusix et al., 2008). One major advantage of cell immobilization in intestinal 295 
fermentation models is the very high microbial and metabolic stability due to entrapment and 
growth of fecal microbiota in polysaccharide beads, which was tested over long fermentation 
periods (up to 7 weeks). 
In this study, we used the same approach with fecal sample immobilization and continuous 
fermentation to develop an original model simulating Salmonella gut infection in children. 300 
We showed that cell immobilization can circumvent problems due to wash-out of exogenous 
enteropathogens observed in conventional in vitro intestinal fermentation models operated 
with planktonic cells (Blake et al., 2003; Carman et al., 2004; Payne et al., 2003). According 
to our initial assumption, addition of S. Typhimurium immobilized in polysaccharide beads 
allowed to recover and maintain S. Typhimurium in the reactor effluents during the entire 305 
fermentation of 43 days. Seven days after addition of S. Typhimurium colonized beads (days 
18-20; STyphi I), the strain was detected at high concentrations (7.5 log10 cells mL-1) in 
effluent samples, in agreement with in vivo concentrations of non-typhoid Salmonella 
shedding of up to 106-107 organisms per gram of faeces measured in some children during 
early convalescence (Cruickshank & Humphrey, 1987). A daily analysis of S. Typhimurium 310 
and commensal bacteria was then performed in effluent samples. A protease treatment was 
used to destroy aggregates before bacterial enumeration with FISH-flow cytometry. However, 
no sample protease treatment was done before analysis with FISH-microscopy. Therefore the 
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aggregation phenomena can explain the lower total and Salmonella cell counts detected with 
FISH-microscopy compared to FISH-flow cytometry. Furthermore the higher inhibition 315 
effects of antibiotics on Salmonella detected with FISH-microscopy compared to FISH-flow 
cytometry can also be due to enhanced cell aggregation observed during antibiotic treatments. 
Total bacteria and bifidobacteria populations measured during STyphi 0 and in feces were 
high and very close. Unfortunately, the other populations could not be determined in feces 
due to a lack of sample. We showed in previous studies that the main populations of child and 320 
adult fecal samples were well preserved during immobilization and long-term continuous 
fermentation. However, differences of microbial balance between the fecal inoculum and 
reactor effluents occurred due to changes of environmental conditions between the host 
intestine and the fermentation model, such as medium composition, pH, and retention time 
(Cinquin et al., 2004; Cinquin et al., 2006b, Cleusix et al., 2008). Such differences are often 325 
observed with in vitro intestinal fermentation systems (Macfarlane & Macfarlane, 2007). 
Furthermore, conditions of the proximal colon applied in the fermentation model are very 
different to that of the distal colon where composition of fecal material is more akin to feces. 
Compared with STyphi 0, S. Typhimurium colonization (STyphi I) induced a strong 
modification in the microbial balance. Bifidobacteria, present in high numbers during 330 
STyphi 0 were significantly decreased, whereas C. cocoides- E. rectale group and Atopobium 
spp. were strongly increased (P < 0.05). In contrast to bacterial populations, metabolites were 
only slightly modified, with only a significant increase in butyrate concentrations during 
STyphi I. This butyrate accumulation may be explained by an increase in the C. cocoides- E. 
rectale group, which contains most of the butyrate producers (Barcenilla et al., 2000). 335 
As expected, addition of amoxicillin in the reactor significantly reduced S. Typhimurium 
concentration in effluent samples and changed the microbial balance. C. coccoides- E. rectale 
and Atopobium populations were strongly inhibited by amoxicillin, whereas Bacteroides, 
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bifidobacteria and total Enterobacteriaceae were not affected. Marked decreases in the C. 
cocoides- E. rectale group have already been described by Barc et al. (2004) in human fecal 340 
flora-associated mice receiving amoxicillin-clavulanic acid (150 mg (kg of body weight)-1) 
for 7 days. The lack of activity of amoxicillin on Bacteroides-Prevotella and 
Enterobacteriaceae was also expected because it is known that certain Bacteroides such as 
Bacteroides fragilis and some Enterobacteriaceae (Klebsiella spp., E. coli) are not inhibited 
during amoxicillin treatments in humans (Sullivan et al., 2001; Floor et al., 1994). Indeed, 345 
resistance to β-lactams via β-lactamase production has been largely described in Bacteroides 
spp. and Enterobacteriaceae (Kader et al., 2004; Papaparaskevas et al., 2005). 
Unexpectedly, bifidobacteria were not inhibited by amoxicillin treatments and their growth 
was even stimulated during ATB I. Although it is generally admitted that bifidobacteria are 
highly sensitive to β-lactams (Moubareck et al., 2005) some strains are resistant to 350 
amoxicillin (Lim et al., 1993; Vlková et al., 2006). However, bifidobacteria overgrowth 
during ATB I may not be directly associated with the effects of antibiotics. It could also be 
due to the strong decrease in the C. coccoides- E. rectale group, which allowed the growth of 
bifidobacteria that came back to their previous concentrations (STyphi 0). It seems that 
bifidobacteria were particularly competitive in the system and that they prevented the 355 
overgrowth of Bacteroides spp. during amoxicillin treatment, contrary to some in vivo 
observations (Christensson et al., 1991). Enterobacteriaceae were not significantly decreased 
during ATB I, and ATB II despite a significant decrease of Salmonella, and became the 
second most dominant group during STyphi II, taking the place of the C. coccoides- E rectale 
group. Such increases in Enterobacteriaceae have also been frequently described in the 360 
literature after amoxicillin treatments in humans (Christensson et al., 1991; Sullivan et al., 
2001). 
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In parallel to modifications of microbial balance during ATB I and II, metabolite ratios were 
also strongly modified. ATB I decreased acetate and increased lactate and formate 
concentrations, whereas butyrate and propionate were not changed compared with STyphi I. 365 
Doubling the amoxicillin concentration (ATB II) also led to a similar decrease in acetate 
concentration compared with STyphi II, but also to twice as much lactate and formate and to a 
decrease in propionate and butyrate concentrations. Lactate and formate are intermediate 
metabolites produced by many different bacteria (Cummings & Macfarlane, 1991), further 
metabolised by other bacteria into CO2 and major SCFA (acetate, propionate or butyrate) 370 
(Duncan et al., 2004; Seeliger et al., 2002). These metabolites generally do not accumulate in 
the human colon (Bernalier et al., 1999). Their accumulation together with the changes in 
SCFA ratios during ABT I and II suggest that lactate- and formate-utilizing bacteria were 
inactivated during amoxicillin treatments. The marked decrease in the C. cocoides-E. rectale 
group, which harbours many lactate-utilizing bacteria (Duncan et al., 2004) is likely 375 
responsible for lactate accumulation during these periods. 
Immobilization of S. Typhimurium and its addition to the recently developed in vitro model 
of intestinal fermentation with immobilized fecal microbiota led to stable high levels of 
S. Typhimurium in the effluent of the continuous gut reactor simulating Salmonella shedding 
observed in certain children. Moreover, immobilization prevented washout of 380 
S. Typhimurium during antibiotic treatments, which allowed comparison of two treatments 
during the same fermentation with the same fecal inoculum. The effects of amoxicillin 
measured with this new in vitro colonic fermentation model for Salmonella infections are in 
agreement with in vivo observations showing a high disturbance of the intestinal microbiota 
balance with decreases in the C. coccoides - E. rectale group and increases in 385 
Enterobacteriaceae ratios. Furthermore, metabolic ratios tested in the in vitro model 
correlated with microbial change, providing further validation to this model. Therefore, this 
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new model is a promising tool for simulating intestinal infections in humans with the aim of 
developing and testing the effects of different antimicrobials on intestinal enteropathogens as 
well as commensal bacteria. 390 
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Tables 
Table 1 Oligonucleotide probes and hybridization conditions used to target predominant 
bacterial groups 
Probes Dyes* Target organisms Formamide 
(%) 
Temperature 
(ºC) 
Probe references 
Sal 3 Cy-3 Salmonella enterica 0 45 Nordentoft et al., 1997 
NonEub338 Cy-5 NA 30 35 Wallner et al., 1993 
Bif 164 Cy-5 Bifidobacterium  30 35 Langendijk et al., 1995 
Bac 303 Cy-5 Bacteroides-Prevotella  30 35 Manz et al., 1996 
Erec 482 Cy-5 C. coccoides-E. rectale  30 35 Franks et al., 1998 
Ato 291 Cy-5 Atopobium  30 35 Harmsen et al., 2000 
Enter 432 Cy-5 Enterobacteria 30 35 Sghir et al., 2000 
Sal 3 Cy-5 Salmonella  30 35 Nordentoft et al., 1997 
*The oligonucleotide probe labelled at the 5’ end with Cy-3 was detected with microscopy 
whereas Cy-5 labelled probes were used in flow cytometry. DAPI and SYBR Green I-stains 
were used for total bacteria enumeration in microscopy and flow cytometry, respectively. 
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Table 2 Bacterial populations in fermentation samples during pseudo-steady states of each treatment 
period measured by FISH-flow cytometry 
 
Bacterial counts (log10 cells mL-1 medium)* 
Bacterial popualtions STyphi 0 STyphi I ATB I STyphi II ATB II STyphi III 
Bifidobacterium 10.2 ± 0.1c   9.0 ± 0.2a 10.5 ± 0.3c   9.9 ± 0.3bc   9.7 ± 0.5ab 10.3 ± 0.1c 
C. coccoides-E. rectale   9.1 ± 0.1bc 10.3 ± 0.3d   8.5 ± 0.1ab   9.5 ± 0.3c   8.4 ± 0.4a   8.5 ± 0.4ab 
Bacteroides   8.8 ± 0.2a   9.0 ± 0.2a   9.0 ± 0.5a   9.0 ± 0.2a   8.6 ± 0.1a   9.0 ± 0.02a 
Atopobium   7.3 ± 0.04a   9.2 ± 0.1c   7.5 ± 0.4a   8.7 ± 0.3bc   8.0 ± 0.5ab   7.2 ± 0.7a 
Enterobacteriaceae NDc   8.9 ± 0.2b   8.2 ± 0.3ab   8.3 ± 0.2ab   7.4 ± 0.3a   9.4 ± 0.3b 
Salmonella  ND   7.5 ± 0.1a NDb   8.1 ± 0.2a NDb   7.6 ± 0.2a 
Total bacteria 10.3 ± 0.4a 10.4 ± 0.2a 10.5 ± 0.1a 10.3 ± 0.1a 10.0 ± 0.3b 10.4 ± 0.2a 
*Data are means ± S.D. for the last 3 days for each fermentation period, n = 2. Values with different 
letters in a row are significantly different with the Tukey's test, P < 0.05. 
¶ND, not detected, below detection limit of the method (log10 6  cells mL-1). 
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Table 3 Metabolite concentrations in effluent samples during pseudo-steady states of each treatment 
period measured by HPLC 
 
Metabolite concentration (mM)* 
Metabolites STyphi 0 STyphi I ATB I STyphi II ATB II STyphi III 
Acetate 69.6 ± 2.1bc 72.5 ± 3.6c 45.9 ± 5.1a 63.6 ± 2.7b 50.1 ± 3.7a 64.8 ± 1.7bc 
Propionate   5.2 ± 0.5b   6.1 ± 2.0bc   6.2 ± 0.6bc   7.5 ± 1.0c   2.2 ± 0.4a   3.8 ± 0.2ab 
Butyrate   6.0 ± 0.1ab 13.5 ± 1.8c 13.3 ± 2.6c   8.2 ± 1.5b   3.9 ± 1.5a   7.9 ± 1.5ab 
Formate NDa¶ NDa   3.8 ± 0.8b NDa   7.2 ± 1.8bc 10.5 ± 1.4c 
Lactate   1.3 ± 0.2a   1.2 ± 0.4a   7.9 ± 1.0b   2.0 ± 0.5a 17.1 ± 3.0c   4.1 ± 1.6d 
Total metabolites 82.1 ± 1.6abc 93.3 ± 4.0c 77.1 ± 4.2a 81.3 ± 2.4abc 80.5 ± 5.1ab 91.2 ± 3.5bc 
*Data are means ± S.D. for the last 3 days for each fermentation period, n = 2. Values with different 
letters in a row are significantly different with the Tukey's test, P < 0.05. 
¶ND, not detected, below detection limit of the method. 
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Figure legends 
Fig. 1. Time schedule of continuous intestinal fermentation experiments during different 
treatment periods: BC, beads colonization; STyphi 0, stabilization of the system, days 3-10; SB, 
addition of S. Typhimurium M557 beads, days 11 and 13; STyphi I, stabilization of 
S. Typhimurium M557 concentrations in effluent samples, days 14-20; ATB I, daily addition of 
90 mg amoxicillin, days 21-25; STyphi II, stabilization period, days 26-34; ATB II, daily 
addition of 180 mg amoxicillin, days 35-39, STyphi III; stabilization period, days 40-43. 
Fig. 2. Total bacteria and Salmonella enumerated by FISH coupled with microscopy. DAPI and 
Cy3 labeled Sal 3-probe were used to detect total bacteria and Salmonella, respectively, during 
the different fermentation periods. STyphi 0, stabilization period I without Salmonella. STyphi 
I, stabilization period II after Salmonella addition; ATB I, first antibiotherapy, 90 mg day-1; 
STyphi II, stabilization period; ATB II, second antibiotherapy, 180 mg day-1; STyphi III, 
stabilization period. Significance is based on last three days of each period. 
Fig. 3. Short chain fatty acids and lactate concentrations in effluent samples during the 43-day 
continuous fermentation. Total metabolites (♦), acetate(●), butyrate (∆), propionate (▲), formate 
(○), lactate (◊). Data are means of triplicate analyses. 
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